RNAZ TRANSCODE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Compliance Regained TransCode Therapeutics, Inc. has regained compliance with the stockholders equity requirement for continued listing on the Nasdaq Capital Market.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC